Sectors

PRQR
ProQR Therapeutics N.V.
1.84
32 x 1.82
12 x 1.83
bid
ask
-
0.04
2.13%
09:52 AM
timesize
Ytd-8.91%
1y-19.30%
1.82
day range
1.90
1.33
52 week range
3.10
Open1.87Prev Close1.88Low1.82High1.90Mkt Cap197.98M
Vol109.18KAvg Vol1.02MEPS-0.50P/E-3.76Forward P/E-5.68
Beta0.04Short Ratio0.31Inst. Own24.96%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg1.63200-d Avg1.871yr Est8.00

PRQR News

benzinga.com
Evercore ISI Group Maintains Outperform on ProQR Therapeutics, Raises Price Target to $6

Evercore ISI Group analyst Gavin Clark-Gartner maintains ProQR Therapeutics (NASDAQ:PRQR) with a

ON Semiconductor To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Friday
benzinga.com
ON Semiconductor To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Friday

Top analysts change outlook on top names: BMO, Chardan, Rosenblatt, Susquehanna, Evercore, Deutsche

benzinga.com
Chardan Capital Maintains Buy on ProQR Therapeutics, Lowers Price Target to $3

Chardan Capital analyst Keay Nakae maintains ProQR Therapeutics (NASDAQ:PRQR) with a Buy and lowe

Small-Cap ProQR Therapeutics Secures Funding From Eli Lilly On Early Trial Success
benzinga.com
Small-Cap ProQR Therapeutics Secures Funding From Eli Lilly On Early Trial Success

ProQR reported positive AX-0810 Phase 1 data and raised $50 million, with Eli Lilly joining a concur

benzinga.com
ProQR Therapeutics Prices Registered Direct Offering Of 27,624,310 Shares At $1.81 Per Share For Tot

ProQR Therapeutics N.V. (NASDAQ:PRQR) ("ProQR"), a clinical-stage biotechnology company dedi

benzinga.com
ProQR Therapeutics Announces Data From Its Ongoing Phase 1 Clinical Study Of AX-0810 Investigational

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target

benzinga.com
ProQR Therapeutics Q1 EPS $(0.15), Inline, Sales $2.381M Miss $5.530M Estimate

ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.15) per share which met the analys

benzinga.com
ProQR Therapeutics Collaborates With Ginkgo Bioworks Over Access To 50+ Instrument Autonomous Lab Ne

ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transf

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga.com
ProQR Therapeutics Q4 EPS $(0.09) Misses $(0.08) Estimate, Sales $5.458M Miss $8.550M Estimate

ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.09) per share which missed the ana

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
ProQR Therapeutics Q3 EPS $(0.10), Inline, Sales $2.882M Miss $8.550M Estimate

ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.10) per share which met the analys

benzinga.com
Chardan Capital Maintains Buy on ProQR Therapeutics, Maintains $4 Price Target

Chardan Capital analyst Keay Nakae maintains ProQR Therapeutics (NASDAQ:PRQR) with a Buy and main

benzinga.com
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesd

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s sessi

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 807 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 1043 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

    Tuesday's session saw 729 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday